185 related articles for article (PubMed ID: 28827665)
1. Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin.
Wang S; Wang A; Shao M; Lin L; Li P; Wang Y
Sci Rep; 2017 Aug; 7(1):8419. PubMed ID: 28827665
[TBL] [Abstract][Full Text] [Related]
2. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
3. Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells.
Li L; Lu Q; Shen Y; Hu X
Biochem Pharmacol; 2006 Feb; 71(5):584-95. PubMed ID: 16405922
[TBL] [Abstract][Full Text] [Related]
4. Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
Thandavarayan RA; Giridharan VV; Arumugam S; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
PLoS One; 2015; 10(3):e0119214. PubMed ID: 25742619
[TBL] [Abstract][Full Text] [Related]
5. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo.
Xu Y; Liu Z; Sun J; Pan Q; Sun F; Yan Z; Hu X
PLoS One; 2011; 6(12):e28335. PubMed ID: 22164272
[TBL] [Abstract][Full Text] [Related]
6. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression.
Wang S; Wang L; Chen M; Wang Y
Chem Biol Interact; 2015 Jun; 235():76-84. PubMed ID: 25824409
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
Sun M; Xu X; Lu Q; Pan Q; Hu X
Cancer Lett; 2007 Feb; 246(1-2):300-7. PubMed ID: 16621244
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.
Guo M; An F; Yu H; Wei X; Hong M; Lu Y
Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885
[TBL] [Abstract][Full Text] [Related]
9. Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity.
Zhang Y; Zhou ZW; Jin H; Hu C; He ZX; Yu ZL; Ko KM; Yang T; Zhang X; Pan SY; Zhou SF
Drug Des Devel Ther; 2015; 9():2001-27. PubMed ID: 25926716
[TBL] [Abstract][Full Text] [Related]
10. Schizandrol A reverses multidrug resistance in resistant chronic myeloid leukemia cells K562/A02.
Arken N
Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):78-83. PubMed ID: 30782299
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3.
Dai X; Yin C; Guo G; Zhang Y; Zhao C; Qian J; Wang O; Zhang X; Liang G
Toxicol Appl Pharmacol; 2018 Nov; 358():110-119. PubMed ID: 30195018
[TBL] [Abstract][Full Text] [Related]
12. Anti-Inflammatory Effects of Schisandrin B on LPS-Stimulated BV2 Microglia via Activating PPAR-γ.
Liu N; Zheng JX; Zhuang YS; Zhou ZK; Zhao JH; Yang L
Inflammation; 2017 Jun; 40(3):1006-1011. PubMed ID: 28303415
[TBL] [Abstract][Full Text] [Related]
13. Differential Action between Schisandrin A and Schisandrin B in Eliciting an Anti-Inflammatory Action: The Depletion of Reduced Glutathione and the Induction of an Antioxidant Response.
Leong PK; Wong HS; Chen J; Chan WM; Leung HY; Ko KM
PLoS One; 2016; 11(5):e0155879. PubMed ID: 27195753
[TBL] [Abstract][Full Text] [Related]
14. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition.
Liu Z; Zhang B; Liu K; Ding Z; Hu X
PLoS One; 2012; 7(7):e40480. PubMed ID: 22848381
[TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.
Huang M; Jin J; Sun H; Liu GT
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1015-26. PubMed ID: 18270702
[TBL] [Abstract][Full Text] [Related]
16. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
[TBL] [Abstract][Full Text] [Related]
17. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.
Yang X; Wang S; Mu Y; Zheng Y
Oncol Rep; 2016 Oct; 36(4):1799-806. PubMed ID: 27499090
[TBL] [Abstract][Full Text] [Related]
18. Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes.
Chiu PY; Luk KF; Leung HY; Ng KM; Ko KM
Life Sci; 2008 May; 82(21-22):1092-101. PubMed ID: 18452952
[TBL] [Abstract][Full Text] [Related]
19. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
Fong WF; Wan CK; Zhu GY; Chattopadhyay A; Dey S; Zhao Z; Shen XL
Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
[TBL] [Abstract][Full Text] [Related]
20. Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein.
Pan Q; Lu Q; Zhang K; Hu X
Cancer Chemother Pharmacol; 2006 Jul; 58(1):99-106. PubMed ID: 16231181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
